Skip to content

Efficacy of septic shock biomakers for the patients with chronic renal failure

Efficacy of septic shock biomakers for the patients with chronic renal failure - Chronic renal failure and septic shock biomarker

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000014208
Enrollment
60
Registered
2014-06-10
Start date
2014-06-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic renal failure

Interventions

None listed

Sponsors

Department of Anesthesiology, Hirosaki University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Chronic renal failure

Exclusion criteria

Exclusion criteria: suspicious of infectious patient

Design outcomes

Primary

MeasureTime frame
Cut off value of Presepsin (soluble CD14) for the patients with chronic renal failure

Countries

Japan

Contacts

Public ContactJunichi Saito

Hirosaki University Graduate School of Medicine Department of anesthesiology

fix-you@hotmail.co.jp0172335112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026